Intracranial hemangiopericytoma: treatment outcomes in a consecutive series

Zentralbl Neurochir. 2007 Aug;68(3):111-8. doi: 10.1055/s-2007-981674. Epub 2007 Jul 30.

Abstract

Objective: The purpose of this study was to analyse a series of patients harbouring an intracranial hemangiopericytoma (HPC) with respect to clinical presentation, treatment results and long-term follow-up outcomes.

Patients and methods: Clinical data were retrospectively obtained in a series of 12 patients who underwent microsurgical resection for HPC at two neurosurgical institutions between 1987 and 2004.

Results: The main presenting symptoms in the seven men and five women (mean age 38 years) were headache in 50% and epileptic seizures in 33% of the patients. A Simpson grade I resection was achieved in seven patients (58%) and none of these patients developed local tumour recurrence after a mean follow-up period of 127 months (10.6 yrs). Only one of these patients received adjuvant radiotherapy. A recurrence of the HPC was observed in all patients (42%) who underwent subtotal tumour resection at first surgery (Simpson grade II or higher). Recurrences occurred after a mean period of 39 months (3.2 yrs) after primary surgery and were effectively controlled by surgical excision, radiotherapy and gamma knife radiosurgery. Two patients (17%) developed extraneural metastases which were treated by surgical excision, radiotherapy and salvage chemotherapy. Poly-chemotherapy was ineffective with respect to tumour control in this study.

Conclusions: The study emphasises the importance of total resection of HPC, defined as a Simpson grade I removal, at first surgery. Adjuvant radiotherapy is recommended after subtotal tumour resections. A life-long vigilant follow-up of these patients is mandatory.

MeSH terms

  • Adult
  • Brain Neoplasms / complications
  • Brain Neoplasms / radiotherapy
  • Brain Neoplasms / surgery*
  • Diagnostic Imaging
  • Epilepsy / etiology
  • Female
  • Follow-Up Studies
  • Hemangiopericytoma / complications
  • Hemangiopericytoma / radiotherapy
  • Hemangiopericytoma / surgery*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis / pathology
  • Neoplasm Recurrence, Local
  • Neurosurgical Procedures*
  • Retrospective Studies
  • Survival
  • Treatment Outcome